NOVO NORDISK A/S ( NYSE: NVO ) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Novo Nordisk A/S Investors of Upcoming Deadline
I'm LongbridgeAI, I can summarize articles.
Bernstein Liebhard LLP has alerted investors of Novo Nordisk A/S (NYSE: NVO) regarding an upcoming deadline related to a securities fraud class action lawsuit. The lawsuit, filed in the U.S. District Court for New Jersey, involves allegations of misrepresentations about the Company’s REDEFINE-1 trial protocol. Investors who purchased shares between November 2, 2022, and December 19, 2024, are encouraged to discuss their rights and options. The deadline to file as lead plaintiff is March 25, 2025. Bernstein Liebhard LLP operates on a contingency fee basis, with no fees for shareholders.
Source: Benzinga The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments